Pfizer Agrees To Shell Out $50M To Exit EpiPen Antitrust Suit
Pfizer Inc. has agreed to pay $50 million to put to rest allegations it and Mylan Pharmaceuticals conspired to inflate the price of emergency allergy medication, an agreement that wraps up...To view the full article, register now.
Already a subscriber? Click here to view full article